Overall, the connection between androgens, ARs, and ALS remains complex and unclear, with evidence suggesting that sex-based differences might play a role 30–32. Therefore, studies have explored androgen antagonists as a potential therapeutic strategy to modify disease progression. It fully manifests in men, typically in their third to fifth decades of life, while women with homozygous mutation have a subclinical disease course, indicating a role of androgen in pathogenesis as opposed to solely the mutant AR . Some neuromuscular conditions exhibit a higher prevalence in men, suggesting a potential pathological role of sex hormones . One study highlighted an association between decreased free testosterone levels and an increased risk of aneurysmal subarachnoid hemorrhage (SAH) in women . However, the impact of androgens on oxidative stress as well as the negative modulation of neurotrophins growth factors may have counterproductive detrimental effects 12, 13. The relationship between androgens and brain development highlights the need to understand their role in neuroplasticity. In this article, we discuss the different forms of endogenous androgen, their function in the CNS, the evolving understanding of the role of androgen in various CNS disorders, and the therapeutic use of androgen supplementation for CNS pathologies. The primary function of androgens involves reproduction and the development of secondary sexual characters. This includes ongoing research exploring the potential therapeutic targets involving the androgen signaling pathway for management of neurological disorders. One of the primary mechanisms through which excessive testosterone can potentially damage the brain is through oxidative stress and neuroinflammation. It’s important to note that under normal circumstances, physiological levels of testosterone are not harmful to the brain. Now, let’s address the elephant in the room – the potential for testosterone to cause brain damage. It’s a reminder that our brains are influenced by a myriad of internal and external factors, with testosterone being just one piece of the puzzle. On the other hand, when levels go awry, it can potentially contribute to various forms of brain damage. On one hand, this hormone helps maintain cognitive sharpness, supports mood regulation, and even promotes neuroplasticity – the brain’s ability to form new neural connections. Thus, highlighting ARs as a potential target for therapies of remyelination 59, 60. To further assess this concept, testosterone treatment was initiated in mice models exposed to toxins causing damage to oligodendrocytes. Finally, additional movement disorders are noted with concomitant hypogonadism, such as ataxia, dystonia, and tremor. Conversely, a retrospective analysis of five men with PD and testosterone deficiency did show significant improvement of refractory non-motor PD symptoms following TRT . Post-menopausal women account for 60% of patients with AD, with female gender being an independent risk factor for development of AD. Age, sex, current endocrine status, but also the timing of testosterone analysis or administration, status of the target tissues and several other factors influence the outcome of observational or interventional studies. Nevertheless, also according to the numerous published studies and animal experiments, testosterone seems to affect brain functions. When testosterone is injected into the hippocampus together with a protein synthesis inhibitor that prevents genomic effects, spatial memory is improved in male rats (Naghdi et al., 2005). The metabolism of testosterone makes studying the physiology of testosterone effects on the brain difficult. Alternatively, aging is strongly related to decline of circulating sex hormones, disrupting thus also circadian rhythms and leading to impaired sleep or cognitive functioning (Urbanski et al., 2014). Furthermore, testosterone supplementation along with exercise in patients with IBM led to an additional decrease in inflammatory response when compared to exercise alone . Preclinical models have demonstrated decreased adipose infiltration in DMD muscles and improved muscle function in female mice treated with oral selective AR modulators . However, experiments with neural AR deletion or overexpression in SOD1-G93 A mice showed no significant impact on disease progression. These observations further support the link between AR dysfunction and pathogenesis of ALS. Amyotrophic Lateral Sclerosis (ALS) has a 20% higher incidence in men than women. SBMA is caused by CAG expansion at the first exon of the androgen receptor gene. In line with these findings is the lack of an association between actual salivary testosterone levels and mental rotation in men and women (Puts et al., 2010). Not surprisingly, observational studies have focused on the association between testosterone and spatial abilities. At least in one small study, depressive women had higher testosterone (Weber et al., 2000). Similarly, in women testosterone concentrations are lower in depressive patients when compared to healthy controls (Kumsar et al., 2014). Nevertheless, it is only one of many biological factors potentially responsible for the sex differences in depression.